Cargando…

Overcoming the growth–infectivity trade‐off in a bacteriophage slows bacterial resistance evolution

The use of lytic bacteriophages for treating harmful bacteria (phage therapy) is faced with the challenge of bacterial resistance evolution. Phage strains with certain traits, for example, rapid growth and relatively broad infectivity ranges, may enjoy an advantage in slowing bacterial resistance ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Quan‐Guo, Chu, Xiao‐Lin, Buckling, Angus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372119/
https://www.ncbi.nlm.nih.gov/pubmed/34429748
http://dx.doi.org/10.1111/eva.13260
_version_ 1783739762920652800
author Zhang, Quan‐Guo
Chu, Xiao‐Lin
Buckling, Angus
author_facet Zhang, Quan‐Guo
Chu, Xiao‐Lin
Buckling, Angus
author_sort Zhang, Quan‐Guo
collection PubMed
description The use of lytic bacteriophages for treating harmful bacteria (phage therapy) is faced with the challenge of bacterial resistance evolution. Phage strains with certain traits, for example, rapid growth and relatively broad infectivity ranges, may enjoy an advantage in slowing bacterial resistance evolution. Here, we show the possibility for laboratory selection programs (“evolutionary training”) to yield phage genotypes with both high growth rate and broad infectivity, traits between which a trade‐off has been assumed. We worked with a lytic phage that infects the bacterium Pseudomonas fluorescens and adopted three types of training strategies: evolution on susceptible bacteria, coevolution with bacteria, and rotation between evolution and coevolution phases. Overall, there was a trade‐off between growth rate and infectivity range in the evolved phage isolates, including those from the rotation training programs. A small number of phages had both high growth rate and broad infectivity, and those trade‐off‐overcoming phages could slow or even completely prevent resistance evolution in initially susceptible bacterial populations. Our findings show the promise of well‐designed evolutionary training programs, in particular an evolution/coevolution rotation selection regime, for obtaining therapeutically useful phage materials.
format Online
Article
Text
id pubmed-8372119
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-83721192021-08-23 Overcoming the growth–infectivity trade‐off in a bacteriophage slows bacterial resistance evolution Zhang, Quan‐Guo Chu, Xiao‐Lin Buckling, Angus Evol Appl Original Articles The use of lytic bacteriophages for treating harmful bacteria (phage therapy) is faced with the challenge of bacterial resistance evolution. Phage strains with certain traits, for example, rapid growth and relatively broad infectivity ranges, may enjoy an advantage in slowing bacterial resistance evolution. Here, we show the possibility for laboratory selection programs (“evolutionary training”) to yield phage genotypes with both high growth rate and broad infectivity, traits between which a trade‐off has been assumed. We worked with a lytic phage that infects the bacterium Pseudomonas fluorescens and adopted three types of training strategies: evolution on susceptible bacteria, coevolution with bacteria, and rotation between evolution and coevolution phases. Overall, there was a trade‐off between growth rate and infectivity range in the evolved phage isolates, including those from the rotation training programs. A small number of phages had both high growth rate and broad infectivity, and those trade‐off‐overcoming phages could slow or even completely prevent resistance evolution in initially susceptible bacterial populations. Our findings show the promise of well‐designed evolutionary training programs, in particular an evolution/coevolution rotation selection regime, for obtaining therapeutically useful phage materials. John Wiley and Sons Inc. 2021-06-19 /pmc/articles/PMC8372119/ /pubmed/34429748 http://dx.doi.org/10.1111/eva.13260 Text en © 2021 The Authors. Evolutionary Applications published by John Wiley & Sons Ltd https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Zhang, Quan‐Guo
Chu, Xiao‐Lin
Buckling, Angus
Overcoming the growth–infectivity trade‐off in a bacteriophage slows bacterial resistance evolution
title Overcoming the growth–infectivity trade‐off in a bacteriophage slows bacterial resistance evolution
title_full Overcoming the growth–infectivity trade‐off in a bacteriophage slows bacterial resistance evolution
title_fullStr Overcoming the growth–infectivity trade‐off in a bacteriophage slows bacterial resistance evolution
title_full_unstemmed Overcoming the growth–infectivity trade‐off in a bacteriophage slows bacterial resistance evolution
title_short Overcoming the growth–infectivity trade‐off in a bacteriophage slows bacterial resistance evolution
title_sort overcoming the growth–infectivity trade‐off in a bacteriophage slows bacterial resistance evolution
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372119/
https://www.ncbi.nlm.nih.gov/pubmed/34429748
http://dx.doi.org/10.1111/eva.13260
work_keys_str_mv AT zhangquanguo overcomingthegrowthinfectivitytradeoffinabacteriophageslowsbacterialresistanceevolution
AT chuxiaolin overcomingthegrowthinfectivitytradeoffinabacteriophageslowsbacterialresistanceevolution
AT bucklingangus overcomingthegrowthinfectivitytradeoffinabacteriophageslowsbacterialresistanceevolution